Christos S Mantzoros (Christos Mantzoros)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 37

Top Topics

Top Venues

Diabetes, obesity & metabolism

Nature communications

Liver international : official journal of the International Association for the Study of the Liver

Therapeutics and clinical risk management

This page only lists publications with an associated author ORCID identifier.

Publications

Sofia K Konstantinidou, Georgia Argyrakopoulou, Stamatia Simati, Konstantinos Stefanakis, Alexander Kokkinos, Antonis Analitis, Christos S Mantzoros
Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration. Diabetes, obesity & metabolism (2024)
Rachelle Haber, Fatima Zarzour, Malak Ghezzawi, Natalie Saadeh, Dania S Bacha, Lama Al Jebbawi, Marlene Chakhtoura, Christos S Mantzoros
The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta-analysis of randomized controlled trials. Diabetes, obesity & metabolism 26 (5) (2024)
Michail Kokkorakis, Emir M Muzurović, Špela Volčanšek, Marlene Chakhtoura, Michael A Hill, Dimitri P Mikhailidis, Christos S Mantzoros
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Pharmacological reviews 76 (3) (2024)
Pavlina Chrysafi, Laura Valenzuela-Vallejo, Konstantinos Stefanakis, Theodoros Kelesidis, Margery A Connelly, Christos S Mantzoros
Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans. Nature communications 15 (1) (2024)
Pavlina Chrysafi, Laura Valenzuela-Vallejo, Konstantinos Stefanakis, Theodoros Kelesidis, Margery A Connelly, Christos S Mantzoros
Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans. Nature communications 15 (1) (2024)
Matina Kouvari, Laura Valenzuela-Vallejo, Evangelos Axarloglou, Ornella Verrastro, Georgios Papatheodoridis, Geltrude Mingrone, Jacob George, Christos S Mantzoros
Thyroid function, adipokines and mitokines in metabolic dysfunction-associated steatohepatitis: A multi-centre biopsy-based observational study. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2024)
Michail Kokkorakis, Emir M Muzurović, Špela Volčanšek, Marlene Chakhtoura, Michael A Hill, Dimitri P Mikhailidis, Christos S Mantzoros
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Pharmacological reviews 76 (3) (2024)
Matina Kouvari, Laura Valenzuela-Vallejo, Evangelos Axarloglou, Ornella Verrastro, Georgios Papatheodoridis, Geltrude Mingrone, Jacob George, Christos S Mantzoros
Thyroid function, adipokines and mitokines in metabolic dysfunction-associated steatohepatitis: A multi-centre biopsy-based observational study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Rachelle Haber, Fatima Zarzour, Malak Ghezzawi, Natalie Saadeh, Dania S Bacha, Lama Al Jebbawi, Marlene Chakhtoura, Christos S Mantzoros
The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta-analysis of randomized controlled trials. Diabetes, obesity & metabolism 26 (5) (2024)
Rachelle Haber, Fatima Zarzour, Malak Ghezzawi, Natalie Saadeh, Dania S Bacha, Lama Al Jebbawi, Marlene Chakhtoura, Christos S Mantzoros
The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta-analysis of randomized controlled trials. Diabetes, obesity & metabolism (2024)
Pavlina Chrysafi, Laura Valenzuela-Vallejo, Konstantinos Stefanakis, Theodoros Kelesidis, Margery A Connelly, Christos S Mantzoros
Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans. Nature communications 15 (1) (2024)
Pavlina Chrysafi, Laura Valenzuela-Vallejo, Konstantinos Stefanakis, Theodoros Kelesidis, Margery A Connelly, Christos S Mantzoros
Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans. Nature communications 15 (1) (2024)
Sofia K Konstantinidou, Georgia Argyrakopoulou, Stamatia Simati, Konstantinos Stefanakis, Alexander Kokkinos, Antonis Analitis, Christos S Mantzoros
Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration. Diabetes, obesity & metabolism 26 (8) (2024)
Matina Kouvari, Laura Valenzuela-Vallejo, Evangelos Axarloglou, Ornella Verrastro, Georgios Papatheodoridis, Geltrude Mingrone, Jacob George, Christos S Mantzoros
Thyroid function, adipokines and mitokines in metabolic dysfunction-associated steatohepatitis: A multi-centre biopsy-based observational study. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2024)
Konstantinos Stefanakis, Alexander Kokkinos, Georgia Argyrakopoulou, Sofia K Konstantinidou, Stamatia Simati, Matina Kouvari, Ajay Kumar, Bhanu Kalra, Melina Kumar, Nikolaos Bontozoglou, Konstantina Kyriakopoulou, Christos S Mantzoros
Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study. Diabetes, obesity & metabolism (2023)
Dimitrios D Raptis, Christos S Mantzoros, Stergios A Polyzos
Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease. Therapeutics and clinical risk management 19 (2023)
Dimitrios D Raptis, Christos S Mantzoros, Stergios A Polyzos
Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease. Therapeutics and clinical risk management 19 (2023)
Emir Muzurović, Carol Chiung-Hui Peng, Matthew J Belanger, Despina Sanoudou, Dimitri P Mikhailidis, Christos S Mantzoros
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors. Hypertension (Dallas, Tex. : 1979) 79 (7) (2022)
Angeliki M Angelidi, Matthew J Belanger, Alexander Kokkinos, Chrysi C Koliaki, Christos S Mantzoros
Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy. Endocrine reviews 43 (3) (2022)
Stergios A Polyzos, Christos S Mantzoros
Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need. Current medical research and opinion 38 (6) (2022)
Kalliopi G Gkouskou, Georgios Georgiopoulos, Ioannis M Vlastos, Evgenia Lazou, Dimitrios Chaniotis, Theodore G Papaioannou, Christos S Mantzoros, Despina Sanoudou, Aristides G Eliopoulos
CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study. International journal of obesity (2005) (2021)
Nikolaos Perakakis, Olivia M Farr, Christos S Mantzoros
Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward- and attention-related brain centres in response to visual food cues in adults with obesity: A cross-sectional functional MRI study. Diabetes, obesity & metabolism 23 (5) (2021)
Kyoung Eun Joung, Sheryl L Rifas-Shiman, Emily Oken, Christos S Mantzoros
Maternal Midpregnancy Leptin and Adiponectin Levels as Predictors of Autism Spectrum Disorders: A Prenatal Cohort Study. The Journal of clinical endocrinology and metabolism 106 (10) (2021)
Yi-Xiang Deng, Lu Lu, Laura Aponte, Angeliki M Angelidi, Vera Novak, George Em Karniadakis, Christos S Mantzoros
Deep transfer learning and data augmentation improve glucose levels prediction in type 2 diabetes patients. NPJ digital medicine 4 (1) (2021)
Nikolaos Perakakis, Konstantinos Stefanakis, Michael Feigh, Sanne S Veidal, Christos S Mantzoros
Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis. Liver international : official journal of the International Association for the Study of the Liver 41 (8) (2021)
Fasiha Kanwal, Jay H Shubrook, Zobair M Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E Rinella, Stephen A Harrison, Christos S Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H Eckel, Davida Kruger, Hashem El-Serag, Kenneth Cusi
Preparing for the NASH Epidemic: A Call to Action. Diabetes care 44 (9) (2021)
Angeliki M Angelidi, Matthew J Belanger, Alexander Kokkinos, Chrysi C Koliaki, Christos S Mantzoros
Novel Non-invasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy. Endocrine reviews (2021)
Sun H Kim, Fahim Abbasi, Clara Nachmanoff, Konstantinos Stefanakis, Ajay Kumar, Bhanu Kalra, Gopal Savjani, Christos S Mantzoros
Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial. Diabetes, obesity & metabolism 23 (2) (2020)
Pavlina Chrysafi, Nikolaos Perakakis, Olivia M Farr, Konstantinos Stefanakis, Natia Peradze, Aleix Sala-Vila, Christos S Mantzoros
Leptin alters energy intake and fat mass but not energy expenditure in lean subjects. Nature communications 11 (1) (2020)
Tuccinardi Dario, Olivia M Farr, Jagriti Upadhyay, Sabrina M Oussaada, Hannah Mathew, Stavroula A Paschou, Nikolaos Perakakis, Anastasia Koniaris, Theodoros Kelesidis, Christos S Mantzoros
Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trial. Diabetes, obesity & metabolism 21 (6) (2019)
Olivia M Farr, Jagriti Upadhyay, Chelsea Rutagengwa, Bridget DiPrisco, Zachary Ranta, Amal Adra, Neha Bapatla, Vivian P Douglas, Konstantinos A A Douglas, Eric Nolen-Doerr, Hannah Mathew, Christos S Mantzoros
Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies. Diabetes, obesity & metabolism 21 (11) (2019)
Tuccinardi Dario, Olivia M Farr, Jagriti Upadhyay, Sabrina M Oussaada, Maria I Klapa, Marco Candela, Simone Rampelli, Sylvain Lehoux, Iolanda Lázaro, Aleix Sala-Vila, Patrizia Brigidi, Richard D Cummings, Christos S Mantzoros
Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross-over, randomized, double-blind, controlled inpatient physiology study. Diabetes, obesity & metabolism 21 (9) (2019)
Natia Peradze, Olivia M Farr, Nikolaos Perakakis, Iolanda Lázaro, Aleix Sala-Vila, Christos S Mantzoros
Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial. Cardiovascular diabetology 18 (1) (2019)
Olivia M Farr, Christos S Mantzoros
Obese individuals with type 2 diabetes demonstrate decreased activation of the salience-related insula and increased activation of the emotion/salience-related amygdala to visual food cues compared to non-obese individuals with diabetes: A preliminary study. Diabetes, obesity & metabolism 20 (10) (2018)
Nikolaos Perakakis, Alexander Kokkinos, Natia Peradze, Nicholas Tentolouris, Wael Ghaly, Dimitrios Tsilingiris, Andreas Alexandrou, Christos S Mantzoros
Follistatins in glucose regulation in healthy and obese individuals. Diabetes, obesity & metabolism 21 (3) (2018)
Olivia M Farr, Dario Tuccinardi, Jagriti Upadhyay, Sabrina M Oussaada, Christos S Mantzoros
Walnut consumption increases activation of the insula to highly desirable food cues: A randomized, double-blind, placebo-controlled, cross-over fMRI study. Diabetes, obesity & metabolism 20 (1) (2017)
Anna Gavrieli, Christos S Mantzoros
Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss. Endocrinology and metabolism (Seoul, Korea) 31 (3) (2016)